These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21795246)

  • 21. Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.
    Steinman TI
    Nephrol Dial Transplant; 2008 Feb; 23(2):431-3. PubMed ID: 18065782
    [No Abstract]   [Full Text] [Related]  

  • 22. Spontaneous coronary artery dissection in a patient with autosomal dominant polycystic kidney disease: a case report.
    Grover P; Fitzgibbons TP
    J Med Case Rep; 2016 Mar; 10():62. PubMed ID: 26971055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
    Chuang SH; Wong HC; Vathsala A; Lee E; How PP
    Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruptured giant liver cyst: a rare cause of acute abdomen in a haemodialysis patient with autosomal dominant polycystic kidney disease.
    Carels RA; van Bommel EF
    Neth J Med; 2002 Oct; 60(9):363-5. PubMed ID: 12572709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Schrier RW
    Semin Nephrol; 1991 Nov; 11(6):653-60. PubMed ID: 1767138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
    Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
    Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
    [No Abstract]   [Full Text] [Related]  

  • 28. Red blood cell Na(+)-K+ pump activity and arterial hypertension in autosomal dominant polycystic kidney disease.
    Boero R; Guarena C; Carbone D; Piccoli G
    Nephron; 1996; 72(2):321. PubMed ID: 8684549
    [No Abstract]   [Full Text] [Related]  

  • 29. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
    Ramanathan G; Periyasamy S; Lakkakula BV
    Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal dominant polycystic kidney disease and hypertension in the aviator.
    Fox KA; Rudge FW
    Aviat Space Environ Med; 1996 Apr; 67(4):376-8. PubMed ID: 8900993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
    Taniguchi M
    Clin Calcium; 2010 Jul; 20(7):1078-87. PubMed ID: 20585187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Cadnapaphornchai MA; Chonchol MB; Schrier RW; Gitomer B
    Am J Nephrol; 2016; 44(3):171-8. PubMed ID: 27548646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular risk in polycystic kidney disease].
    Di Lorenzo A; Stallone G; Infante B; Grandaliano G; Schena FP
    G Ital Cardiol (Rome); 2015 Sep; 16(9):479-84. PubMed ID: 26418387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal dominant polycystic kidney disease, type 2 (PKD2 disease).
    Torra R
    Adv Nephrol Necker Hosp; 1999; 29():277-87. PubMed ID: 10561750
    [No Abstract]   [Full Text] [Related]  

  • 35. Autosomal dominant polycystic kidney disease.
    Simms RJ
    BMJ; 2016 Feb; 352():i679. PubMed ID: 26868522
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular calcification in chronic kidney disease].
    Cozzolino M; Missaglia E; Ortiz A; Bellasi A; Adragao T; Apostolous T; Vescovo G; Gallieni M
    Recenti Prog Med; 2010 Nov; 101(11):442-52. PubMed ID: 21197764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function.
    Lee DI; Andreoni CR; Rehman J; Landman J; Ragab M; Yan Y; Chen C; Shindel A; Middleton W; Shalhav A; McDougall EM; Clayman RV
    J Endourol; 2003 Aug; 17(6):345-54. PubMed ID: 12965058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of pain in autosomal dominant polycystic kidney disease and anatomy of renal innervation.
    Tellman MW; Bahler CD; Shumate AM; Bacallao RL; Sundaram CP
    J Urol; 2015 May; 193(5):1470-8. PubMed ID: 25534330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.